The abnormalities of carbohydrate metabolism in Turner syndrome: Analysis of risk factors associated with impaired glucose tolerance

European Journal of Pediatrics

Volumn 164, Issue 7, 2005, Pages 442-447

  Choi, In Kyoung ^a   Kim, Duk Hee ^a   Kim, Ho Seong ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Homeostasis model assessment; Impaired glucose tolerance; Oral glucose tolerance test; Quantitative insulin sensitivity check index; Turner syndrome

Indexed keywords

C PEPTIDE; CARBOHYDRATE; GLUCOSE; INSULIN; PROINSULIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISORDERS OF CARBOHYDRATE METABOLISM; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; TURNER SYNDROME;

ADOLESCENT; ADULT; C-PEPTIDE; CHILD; CHILD, PRESCHOOL; COMORBIDITY; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN; PROINSULIN; RISK FACTORS; TURNER SYNDROME;

EID: 21644484248     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-005-1643-x     Document Type: Article

References (36)

1. Andres R, Swerdloff R, Pozefsky T, Coleman D (1966) Manual feedback techniques for control of glucose concentration. In: Skeegs LT (ed) Automation in analytic chemistry. Medaid, New York, pp 486-491
2. Bakalov VK, Cooley MM, Quon MJ, Luo ML, Yanovski JA, Nelson LM, Sullivan G, Bondy CA (2004) Impaired insulin secretion in the Turner metabolic syndrome. J Clin Endocrinol Metab 89: 3516-3520
3. Bergman RN (1989) Lilly Lecture 1989. Towards physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 38: 1512-1527
4. Bergman RN, Finegood DT, Ader M (1985) Assessment of insulin sensitivity in vivo. Endocr Rev 6: 45-86
5. Bergman RN, Prager R, Volund A, Olefsky JM (1987) Equivalence of the isulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79: 790-800
6. Caprio S, Boulware S, Diamond M, Sherwin RS, Carpenter TO, Rubin K, Amiel S, Press M, Tamborlane WV (1991) Insulin resistance:an early metabolic defect of Tuener's syndrome. J Clin Endocrinol Metab 72: 832-836
7. Caprio S, Boulware S, Press M, Sherwin RS, Rubin K, Carpenter TO, Plewe G, Tamborlane WV (1992) Effect of growth hormone treatment on hyperinsulinemia associated with Turner syndrome. J Pediatr 120: 238-243
8. Cicognani A, Mazzanti L, Tassinari D, Pellacanti A, Forabosco A, Land L (1988) Differences in carbohydrate tolerance in Turner syndrome depending on age and karyotype. Pediatrics 12: 1072-1080
9. Davis SN, Monti L, Piatti PM, Moller N, Ng L, Coppack S, May M, Brown MD, Orskov H, Alberti KG (1993) Estimates of insulin action in normal, obese and NIDDM man: comparison of insulin and glucose infusion test, CIGMA, minimal model and glucose clamp techniques. Diabetes Res 23: 1-18
10. DeFronzo RA (1997) Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 5: 177-269
11. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-E223
12. Fagot-Compagna A, Saadine J, Flegal KM, Beckles GL (2001) Diabetes, impaired fasting glucose and elevated HBA1c in US adolescents: the Third National Health and Nutrition Examination Survey. Diabetes Care 24[Suppl 5]: S134-S137
13. Gerich JE (1998) The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev 19: 491-503
14. Gravholt CH, Juul S, Naeraa RW, Hansen J (1998) Morbidity in Turner syndrome. J Clin Epidemiol 51: 147-158
15. Haffner SM, Gonzalez C, Mykkänen L, Stern M (1997) Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study. Diabetologia 40: 830-837
16. Hrebicek J, Janout V, Malincikova J, Horakova D, Cizek L (2002) Detection of insulin resistance by simple quantitative insulin check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab 87: 144-147
17. Karp M, Sniz A, Dozon M (1975) Glucose tolerance tests and insulin response in juvenile patients with gonadal dysgenesis. Mod Probl Paediatr 12: 251-257
18. Katsuki A, Sumida Y, Gabazza EC, Murashima S, Urakawa H, Morioka K, Kitagawa N, Tanaka T, Araki-Sasaki R, Hori Y, Nakatani K, Yano Y, Adachi Y (2002) QUICKI is useful for following improvements in insulin sensitivity after therapy in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 87: 2906-2908
19. Katz A, Nambi SS, Mather K, Baron AD, Follman DA, Sullivan G, Quon MJ (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85: 2402-2410
20. Lippe B, Rosenfeld RG, Hintz RL, Johanson AJ, Frane J, Sherman B (1988) Treatment of Turner syndrome with recombinant human growth hormone (somatrem). Acta Pediatr Scand 343: 47-52
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 23: 412-419
22. Mykkänen L, Haffner SM, Kuusisto J, Pyorala K, Hales CN, Laasko M (1995) Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia 38: 1176-1182
23. Naeraa RW, Gravholt CH, Hansen J, Nielsen J, Juul S (1995) Mortality in Turner syndrome. In: Albertsson-Wikland K, Ranke MB (eds) Turner syndrome in a life span perspective: research and clinical aspects. Elsevier, Amsterdam, pp 323
24. Neufeld ND, Lippe B, Sperling MA (1976) Carbohydrate intolerance in gonadal dysgenesis: a new model of insulin resistance. Diabetes 25: 379
25. Nielsen J, Johansen K, Yde H (1969) The frequency of diabetes mellitus in patients with Turner's syndrome and pure gonadal dysgenesis:blood glucose, plasma insulin and growth hormone level during an oral glucose tolerance test. Acta Endocrinol Copenh 62: 251-269
26. Nijpels G, Popp-Snijders C, Kostense PJ, Bouter LM, Heine RJ (1996) Fasting proinsulin and 2-h post load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn study. Diabetologia 39: 113-118
27. Pareren YK, Muinck Keizer-Schrama SMPF, Stijnen T, Drop SLS, The Dutch Advisory Group on Growth Hormone (2002) Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome. J Clin Endocrinol Metab 87: 5442-5448
28. Polychronakos C, Letarte J, Collu R, Ducharme JR (1980) Carbohydrate intolerance in children and adolescents with Turner syndrome. J Pediatr 96: 1009-1014
29. Rasio E, Antaki A, Van Campenhout J (1976) Diabetes mellitus in gonadal dysgenesis: studies of insulin and growth hormone secretion. Eur J Clin Invest 6: 59-66
30. Roder ME, Porte D, Schwartz RS, Kahn SE (1998) Disproportionately elevated proinsulin levels reflect the degree of impaired β-cell secretory capacity in patients with non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 83: 604-608
31. Saad MF, Steil GM, Kades WW (1997) Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols. Diabetes 46: 1167-1171
32. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S (2002) Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346: 802-810
33. Stoppoloni G, Prisco F, Alfano C, Iafusco D, Marrazzo G, Paolisso G (1990) Characteristics of insulin resistance in Turner syndrome. Diabetes Metab 16: 267-271
34. The Expert Committee on the Diagnosis and Classification of Diabetes mellitus (1999) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 22[Suppl 1]: S5-S19
35. Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN (1999) Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care 22: 262-270
36. Wilson DM, Frane JW, Sherman B (1988) Turner syndrome: effect of therapy with with growth hormone, oxandrolone, and a combination of both. J Pediatr 112: 210-217